Provided by Tiger Trade Technology Pte. Ltd.

Arcus Biosciences Inc.

22.52
+0.31001.40%
Volume:448.00K
Turnover:10.00M
Market Cap:2.82B
PE:-6.84
High:22.86
Open:21.95
Low:21.71
Close:22.21
52wk High:26.40
52wk Low:6.50
Shares:125.35M
Float Shares:88.65M
Volume Ratio:0.48
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2900
EPS(LYR):-3.2900
ROE:-63.26%
ROA:-21.08%
PB:4.47
PE(LYR):-6.84

Loading ...

Jun 05, 2020

Major Issues Report

8-K - Current report
May 29, 2020

Major Issues Report

8-K - Current report
May 27, 2020

Major Issues Report

8-K - Current report
May 26, 2020

Major Issues Report

8-K - Current report
May 05, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 05, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 07, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Mar 05, 2020

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Mar 05, 2020

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Mar 05, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 05, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 27, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Dec 12, 2019

Major Issues Report

Current report, item 5.02
Nov 25, 2019

Major Issues Report

[Amend] Current report, item 5.02
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01